These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 23592414)

  • 1. The 2013 Ebert Prize was presented to Professor Benet and his coauthor Dr. Reyes.
    Borchardt RT
    J Pharm Sci; 2013 Sep; 102(9):2910-1. PubMed ID: 23592414
    [No Abstract]   [Full Text] [Related]  

  • 2. Progressive applications of dissolution, its impact, and implications in the pharmaceutical world.
    Shah VP
    J Pharm Sci; 2013 Sep; 102(9):2895-7. PubMed ID: 23728620
    [No Abstract]   [Full Text] [Related]  

  • 3. Perspectives on a pharmacokinetics legend: C versus T (contributions over time).
    Hammarlund-Udenaes M; Brouwer K; Nakashima E; Terasaki T
    J Pharm Sci; 2013 Sep; 102(9):2889-94. PubMed ID: 23744575
    [No Abstract]   [Full Text] [Related]  

  • 4. 2009 Ebert Prize. Editorial.
    Borchardt RT
    J Pharm Sci; 2009 Jul; 98(7):2237. PubMed ID: 19475657
    [No Abstract]   [Full Text] [Related]  

  • 5. From adverse drug reactions to drug disposition to WHO and essential medicines to our discipline of clinical pharmacology.
    Reidenberg MM
    Clin Pharmacol Ther; 2010 Feb; 87(2):163-5. PubMed ID: 20107452
    [No Abstract]   [Full Text] [Related]  

  • 6. Biowaiver: an alternative to in vivo pharmacokinetic bioequivalence studies.
    Mishra V; Gupta U; Jain NK
    Pharmazie; 2010 Mar; 65(3):155-61. PubMed ID: 20383933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the full potential of the biopharmaceutics classification system reached?
    Bergström CA; Andersson SB; Fagerberg JH; Ragnarsson G; Lindahl A
    Eur J Pharm Sci; 2014 Jun; 57():224-31. PubMed ID: 24075971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Young investigator: Wahajuddin.
    Wahajuddin
    Bioanalysis; 2011 Apr; 3(8):839-41. PubMed ID: 21510757
    [No Abstract]   [Full Text] [Related]  

  • 9. Temperature dependence of skin permeability to hydrophilic and hydrophobic solutes.
    Mitragotri S
    J Pharm Sci; 2007 Jul; 96(7):1832-9. PubMed ID: 17094128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syntex and the Syntex Prize.
    Proc West Pharmacol Soc; 1996; 39():107. PubMed ID: 8895978
    [No Abstract]   [Full Text] [Related]  

  • 11. Biopharmaceutical classification of drugs using intrinsic dissolution rate (IDR) and rat intestinal permeability.
    Zakeri-Milani P; Barzegar-Jalali M; Azimi M; Valizadeh H
    Eur J Pharm Biopharm; 2009 Sep; 73(1):102-6. PubMed ID: 19442726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of lipophilia of drugs for their distribution in the body].
    Krieglstein J
    Dtsch Med Wochenschr; 1973 Aug; 98(32):1509-10. PubMed ID: 4579809
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes of pharmacokinetics in uremia with special reference to drug catabolism].
    Leber HW
    Med Klin; 1976 Aug; 71(34):1321-30. PubMed ID: 785180
    [No Abstract]   [Full Text] [Related]  

  • 14. An improved prediction of the human in vivo intestinal permeability and BCS class of drugs using the in vitro permeability ratio obtained for rat intestine using an Ussing chamber system.
    Li H; Jin HE; Shim WS; Shim CK
    Drug Dev Ind Pharm; 2013 Oct; 39(10):1515-22. PubMed ID: 22934579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of uremia on glucuronization of drugs in rat liver microsomes].
    Leber HW; Gleumes A; Schütterle G
    Verh Dtsch Ges Inn Med; 1973; 79():711-3. PubMed ID: 4789956
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biopharmaceutical classification system--experimental model of the prediction of drug bioavailability].
    Golovenko NIa; Borisiuk IIu
    Biomed Khim; 2008; 54(4):392-407. PubMed ID: 18988456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling promiscuity based on in vitro safety pharmacology profiling data.
    Azzaoui K; Hamon J; Faller B; Whitebread S; Jacoby E; Bender A; Jenkins JL; Urban L
    ChemMedChem; 2007 Jun; 2(6):874-80. PubMed ID: 17492703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The developability classification system: application of biopharmaceutics concepts to formulation development.
    Butler JM; Dressman JB
    J Pharm Sci; 2010 Dec; 99(12):4940-54. PubMed ID: 20821390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A non-binary biopharmaceutical classification of drugs: the ABΓ system.
    Macheras P; Karalis V
    Int J Pharm; 2014 Apr; 464(1-2):85-90. PubMed ID: 24456673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.